A LINK BETWEEN ACTIVE MYELOPEROXIDASE AND CHLORINATED CERULOPLASMIN IN BLOOD PLASMA OF PATIENTS WITH CARDIOVASCULAR DISEASES

Myeloperoxidase is a key factor promoting development of halogenative/oxidative stress under inflammatory conditions. Previously, we have discovered complexes including myeloperoxidase and its physiological inhibitor, ceruloplasmin in blood plasma of patients with inflammatory diseases of different etiology, e.g., atherosclerosis. Studies on regulation of myeloperoxidase activity by ceruloplasmin have shown that hypochlorous acid, a specific product of myeloperoxidase action, is likely to modify ceruloplasmin during inflammation. The present study was aimed for analysis of relationships between the myeloperoxidase activity, native, and HOCl-modified ceruloplasmin levels in blood plasma samples of the patients with cardiovascular diseases.

Specific antibodies against myeloperoxidase, ceruloplasmin, and HOCl-modified ceruloplasmin were obtained and specific enzyme-linked immunosorbent assays (ELISA) were developed. A combination of highly sensitive methods of myeloperoxidase assay i.e., solid-phase adsorption of antigens with subsequent testing of either their activity, or peroxidase-labeled antibody activity allowed elaborating the highly sensitive assays for ceruloplasmin and its HOCl-modified molecules, and for myeloperoxidase (concentration, peroxidase and halogenating activity). Positive correlation was proven between the myeloperoxidase concentration and activities. HOCl-modified ceruloplasmin content also correlated with myeloperoxidase activity.

The HOCl-modified ceruloplasmin was first discovered in blood plasma samples from patients with cardiovascular diseases. In view of correlation between myeloperoxidase activity and HOCl-modified ceruloplasmin content in plasma, we suggest that HOCl production is aimed for suppression of myeloperoxidaseinhibitory function of ceruloplasmin.

1. Belik I.V., Ivantsova A.A., Mamedova Z.E., Denisenko A.D. Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis. Biomeditsinskaya khimiya = Biomedical Chemistry, 2016, Vol. 62, pp. 471-475.(In Russ.)

2. Bunenkov N.S., Komok V.V., Sokolov A.V., Nemkov A.S. New methods of intraoperative evaluation of myocardial ischemic-reperfusion injury during on-and off-pump coronary artery bypass grafting. Klinicheskaya i eksperimental’naya khirurgiya. Zhurnal imeni Akademika B.V. Petrovskogo = Clinical and Experimental. Surgery Petrovsky Journal, 2017, Vol. 16, no. 2, pp. 40-48.(In Russ.)

3. Gorudko I.V.,Cherkalina O.S., Sokolov A.V., Pulina M.O., Zakharova E.T., Vasilyev V.B., Cherenkevich S.N., Panasenko O.M. New approaches to the measurement of the concentration and peroxidase activity of myeloperoxidase in human blood plasma. Bioorganicheskaya khimiya = Bioorganic Chemistry, 2009, Vol. 35, pp. 629-639.(In Russ.)

4. Grigorieva D.V., Gorudko I.V., Kostevich V.A., Sokolov A.V., Buko I.V., Vasilyev V.B., Polonetsky L.Z., Panasenko O.M., Cherenkevich S.N. Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease. Biomeditsinskaya khimiya = Biomedical Chemistry, 2016, Vol. 62, pp. 318-324.(In Russ.)

5. Grigorieva D.V., Gorudko I.V., Sokolov A.V., Kosmachevskaya O.V., Topunov A.F., Buko I.V., Konstantinova E.E., Cherenkevich S.N., Panasenko O.M. Measurement of plasma hemoglobin peroxidase activity. Byulleten eksperimentalnoy biologii i meditsiny = Bulletin of Experimental Biology and Medicine, 2013, Vol. 155, no. 9, pp. 129-132.(In Russ.)

6. Mikhalchik E.V., Smolina N.V., Astamirova T.C., Gorudko I.V., Grigoryeva D.V., Ivanov V.A., Sokolov A.V., Kostevich V.A., Cherenkevich S.N., Panasenko O.M. Human serum albumin modified under oxidative/halogenative stress enhances luminol-dependent chemiluminescence of human neutrophils. Biofizika = Biophysics, 2013, Vol. 58, pp. 681-689.(In Russ.)

7. Панасенко О.М., Горудко И.В., Соколов А.В. Хлорноватистая кислота как предшественник свободных радикалов в живых системах // Успехи биологической химии, 2013. Т. 53. С. 195-244. [Panasenko O.M., Gorudko I.V., Sokolov A.V. Hypochlorous acid as a precursor of free radicals in living systems. Uspekhi biologicheskoy khimii = Advances in Biological Chemistry, 2013, Vol. 53, pp. 195-244.(In Russ.)]

8. Panasenko O.M., Mikhalchik E.V., Gorudko I.V., Grigorieva D.V., Sokolov A.V., Kostevich V.A., Vasilyev V.B., Cherenkevich S.N. The effects of antioxidants and hypohalous acid scavengers on neutrophil activation by hypochlorous acid-modified low-density lipoproteins.Biofizika = Biophysics, 2016, Vol. 61, pp. 500-509.(In Russ.)

9. Panasenko O.M., Chekanov A.V., Vlasova I.I., Sokolov A.V., Ageeva K.V., Pulina M.O., Cherkalina O.S., Vasilyev V.B. A study of the effect of ceruloplasmin and lactoferrin on the chlorination activity of leukocytic myeloperoxidase using the chemiluminescence method. Biofizika = Biophysics, 2008, Vol. 53, pp. 573-581.(In Russ.)

10. Sokolov A.V., Ageeva K.V., Kostevich V.A., Berlov M.N., Runova O.L., Zakharova E.T., Vasilyev V.B. Study of interaction of ceruloplasmin with serprocidins. Biokhimiya = Biochemistry (Moscow), 2010, Vol. 75, pp. 1544-1552. (In Russ.)

11. Sokolov A.V., Pulina M.O., Ageeva K.V., Runova O.L., Zakharova E.T., Vasilyev V.B. Identification of leukocyte cationic proteins that interact with ceruloplasmin. Biokhimiya = Biochemistry (Moscow), 2007, Vol. 72, pp. 1072-1077.(In Russ.)

12. Sokolov A.V., Pulina M.O., Ageeva K.V., Cherkalina O.S., Zakharova E.T., Vasilyev V.B. Identification of complexes formed by ceruloplasmin with matrix metalloproteinases 2 and 12. Biokhimiya = Biochemistry (Moscow), 2009, Vol. 74, pp. 1703-1708.(In Russ.)

13. Sokolov A.V., Kostevich V.A., Romanico D.N., Zakharova E.T., Vasilyev V.B. Two-stage method for purification of ceruloplasmin based on its interaction with neomycin. Biokhimiya = Biochemistry (Moscow), 2012, Vol. 77, pp. 775-784.(In Russ.)

14. Bakkenist A.R., Wever R., Vulsma T., Plat H., van Gelder B.F. Isolation procedure and some properties of myeloperoxidase from human leucocytes. Biochim. Biophys. Acta, 1978, Vol. 524, pp. 45-54.

15. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Münzel T., Simoons M.L., Hamm C.W. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, 2003, Vol. 108, pp. 1440-1445.

16. Beers R.F.Jr., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.J. Biol. Chem., 1952, Vol. 195, pp. 133-140.

17. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest., 1994, Vol. 94, pp. 437-444.

18. Davis B.J. Disc electrophoresis. II. Method and application to human serum proteins.Ann. N. Y. Acad. Sci., 1964, Vol. 121, pp. 404-427.

19. Fling S.P., Gregerson D.S. Peptide and protein molecular weight determination by electrophoresis using a high-molarity tris buffer system without urea. Anal. Biochem., 1986, Vol. 155, pp. 83-88.

20. Franck T., Minguet G., Delporte C., Derochette S., Zouaoui Boudjeltia K., van Antwerpen P., Gach O., Deby-Dupont G., Mouithys-Mickalad A., Serteyn D. An immunological method to combine the measurement of active and total myeloperoxidase on the same biological fluid, and its application in finding inhibitors which interact directly with the enzyme.Free Radic. Res., 2015, Vol. 49, pp. 790-799.

21. Gorudko I.V., Grigorieva D.V., Shamova E.V., Kostevich V.A., Sokolov A.V., Mikhalchik E.V., Cherenkevich S.N., Arnhold J., Panasenko O.M. Hypohalous acid-modified human serum albumin induces neutrophil NADPH-oxidase activation, degranulation and shape change. Free Radic. Biol. Med., 2014, Vol. 68, pp. 326-334.

22. Morris J.C. The acid ionization constant of HOCl from 5° to 35°. J. Phys. Chem., 1966, Vol. 70, pp. 3798-3805.

23. Noyer M., Dwulet F.E., Hao Y.L., Putnam F.W. Purification and characterization of undegraded human ceruloplasmin. Anal. Biochem., 1980, Vol. 102, pp. 450-458.

24. Samygina V.R., Sokolov A.V., Bourenkov G., Petoukhov M.V., Pulina M.O., Zakharova E.T., Vasilyev V.B., Bartunik H., Svergun D.I. Ceruloplasmin: macromolecular assemblies with iron-containing acute phase proteins. PLoS ONE, 2013. Vol. 8, e67145.doi: 10.1371/journal.pone.0067145.

25. Schultz J., Kaminker K. Myeloperoxidase of the leukocyte of normal human blood. I. Content and localization. Arch. Biochem. Biophys., 1962, Vol. 96, pp. 465-467.

26. Sokolov A.V., Acquasaliente L., Kostevich V.A., Frasson R., Zakharova E.T., Pontarollo G., Vasilyev V.B., de Filippis V. Thrombin inhibits the anti-myeloperoxidase and ferroxidase functions of ceruloplasmin: relevance in rheumatoid arthritis. Free Radic. Biol. Med., 2015, Vol. 86, pp. 279-294.

27. Sokolov A.V., Ageeva K.V., Cherkalina O.S., Pulina M.O., Zakharova E.T., Prozorovskii V.N., Aksenov D.V., Vasilyev V.B., Panasenko O.M. Identification and properties of complexes formed by myeloperoxidase with lipoproteins and ceruloplasmin. Chem. Phys. Lipids, 2010, Vol. 163, pp. 347-355.

28. Sokolov A.V., Ageeva K.V., Pulina M.O., Cherkalina O.S., Samygina V.R., Vlasova I.I., Panasenko O.M., Zakharova E.T., Vasilyev V.B. Ceruloplasmin and myeloperoxidase in complex affect the enzymatic properties of each other. Free Radic. Res., 2008, Vol. 42, pp. 989-998.

29. Sokolov A.V., Chekanov A.V., Kostevich V.A., Aksenov D.V., Vasilyev V.B., Panasenko O.M. Revealing binding sites for myeloperoxidase on the surface of human low density lipoproteins. Chem. Phys. Lipids, 2011, Vol. 164, pp. 49-53.

30. Sokolov A.V., Kostevich V.A., Kozlov S.O., Donskyi I.S., Vlasova I.I., Rudenko A.O., Zakharova E.T., Vasilyev V.B., Panasenko O.M. Kinetic method for assaying the halogenating activity of myeloperoxidase based on reaction of celestine blue B with taurine halogenamines. Free Radic. Res., 2015, Vol. 49, pp. 777-789.

31. Sokolov A.V., Kostevich V.A., Runova O.L., Gorudko I.V., Vasilyev V.B., Cherenkevich S.N., Panasenko O.M. Proatherogenic modification of LDL by surface-bound myeloperoxidase. Chem. Phys. Lipids, 2014, Vol. 180, pp. 72-80.

32. Sokolov A.V., Kostevich V.A., Zakharova E.T., Samygina V.R., Panasenko O.M., Vasilyev V.B. Interaction of ceruloplasmin with eosinophil peroxidase as compared to its interplay with myeloperoxidase: Reciprocal effect on enzymatic properties. Free Radic. Res., 2015, Vol. 49, pp. 800-811.

33. Sokolov A.V., Zakahrova E.T., Kostevich V.A., Samygina V.R., Vasilyev V.B. Lactoferrin, myeloperoxidase, and ceruloplasmin: complementary gearwheels cranking physiological and pathological processes. Biometals, 2014, Vol. 27, pp. 815-828.

34. van Dalen C.J., Whitehouse M.W., Winterbourn C.C., Kettle A.J. Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem. J., 1997, Vol. 327, pp. 487-492.

35. Varfolomeeva E.Y., Semenova E.V., Sokolov A.V., Aplin K.D., Timofeeva K.E., Vasilyev V.B., Filatov M.V. Ceruloplasmin decreases respiratory burst reaction during pregnancy.Free Radic. Res., 2016, Vol. 50, pp. 909-919.

36. Vlasova I.I., Sokolov A.V., Arnhold J. The free amino acid tyrosine enhances the chlorinating activity of human myeloperoxidase. J. Inorg. Biochem., 2012, Vol. 106, pp. 76-83.